Metabolomics and first-trimester prediction of early-onset preeclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 10, 2012, Pages 1840-1847

  Bahado Singh, Ray O ^a   Akolekar, Ranjit ^b   Mandal, Rupasri ^c   Dong, Edison ^c   Xia, Jianguo ^c   Kruger, Michael ^a   Wishart, David S ^c   Nicolaides, Kypros ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

First trimester screening; Metabolomics; Preeclampsia; Uterine artery Doppler

Indexed keywords

ALKANOIC ACID; CITRIC ACID; GLYCEROL; HYDROXYISOVALERIC ACID; METHIONINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CROWN RUMP LENGTH; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOPPLER ECHOGRAPHY; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC ANALYSIS; GESTATIONAL AGE; HEMODYNAMIC PARAMETERS; HUMAN; MATERNAL PLASMA; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREECLAMPSIA; PRIORITY JOURNAL; PULSATILITY INDEX; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; UTERINE ARTERY;

ADULT; ALGORITHMS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CITRIC ACID; DECISION SUPPORT TECHNIQUES; FEMALE; FETAL DEVELOPMENT; GLYCEROL; HUMANS; LEAST-SQUARES ANALYSIS; LOGISTIC MODELS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; METHIONINE; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; UTERINE ARTERY; VALERATES;

EID: 84866382213     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2012.680254     Document Type: Article

References (38)

1. Villar J, Say L, Gulmezoghe AM, Merialdi M, Lindheimer M, Beltran AP, et al. Eclampsia and preeclampsia: a worldwide health problem for 2000 years. In: Critchley H, MacLean A, Poston L, Walker J, editors. Preeclampsia. London, UK: RCOG; 2003.
2. Maternal Mortality in 2005. Estimates developed by WHO, UNICEF, UNFPA and the World Bank. Geneva, Switzerland: World Health Organization 2007.
3. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974.
4. Yu CK, Khouri O, Onwudiwe N, Spiliopoulos Y, Nicolaides KH; Fetal Medicine Foundation Second-Trimester Screening Group. Prediction of pre-eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small-for-gestational age. Ultrasound Obstet Gynecol 2008;31:310-313.
5. Witlin AG, Saade GR, Mattar F, Sibai BM. Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation. Am J Obstet Gynecol 2000;182:607-611. (Pubitemid 30207320)
6. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001;323:1213-1217.
7. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy 2003;22:143-148. (Pubitemid 37521365)
8. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol 2011;204:193-201.
9. Wikström AK, Larsson A, Eriksson UJ, Nash P, Nordén-Lindeberg S, Olovsson M. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol 2007;109:1368-1374. (Pubitemid 46869876)
10. Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 2009;37:D603-D610.
11. Villas-Bôas SG, Mas S, Akesson M, Smedsgaard J, Nielsen J. Mass spectrometry in metabolome analysis. Mass Spectrom Rev 2005;24: 613-646. (Pubitemid 41621943)
12. Wishart DS. Advances in metabolite identification. Bioanalysis 2011;3: 1769-1782.
13. Gowda GA, Zhang S, Gu H, Asiago V, Shanaiah N, Raftery D. Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn 2008;8:617-633.
14. Robinson HP, Fleming JE. A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol 1975;82:702-710.
15. Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenat Diagn 2011;31:90-102.
16. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2007;30:742-749. (Pubitemid 47612696)
17. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20: IX-XIV. (Pubitemid 32672922)
18. Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, Sinelnikov I, et al. The human serum metabolome. PLoS ONE 2011;6:e16957.
19. Saude EJ, Slupksy CM, Sykes BD. Optimization of NMR analysis of biological fluids for quantitative accuracy. Metabolom ICD 2006;2: 113-123. (Pubitemid 44473570)
20. Wishart DS. Computational approaches to metabolomics. Methods Mol Biol 2010;593:283-313.
21. Xia J, Psychogios N, Young N, Wishart DS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 2009;37:W652-W660.
22. Bijlsma S, Bobeldijk I, Verheij ER, Ramaker R, Kochhar S, Macdonald IA, van Ommen B, Smilde AK. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem 2006;78:567-574. (Pubitemid 43100391)
23. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36. (Pubitemid 12142173)
24. Kell D. Genetic computing: defence against the flood: a solution to the data mining and predictive modeling challenges of today. Bioinforma World 2002;1:16-18.
25. Kell DB. Metabolomics and machine learning: explanatory analysis of complex metabolome data using genetic programming to produce simple, robust rules. Mol Biol Rep 2002;29:237-241. (Pubitemid 35021892)
26. Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 2011;40:387-426.
27. Bijlsma S, Bodelijk I, Verheij E, Ramaker R, Kochhar S, MacDonald IA, et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem 2006;78:567-574. (Pubitemid 43100391)
28. Demircio O, Tugriel AS, Dolgun N, Sozen H, Eren S. Serum lipid levels assessed in early pregnancy and the risk of pre-eclampsia. J Obstet Gyencol Res 2011 doi: 10.1111/j.1447-0756.2011.01562
29. Acilmis YG, Dikensoy E, Kutlar AI, Balat O, Cebesoy FB, Ozturk E, Cicek H, Pence S. Homocysteine, folic acid and vitamin B12 levels in maternal and umbilical cord plasma and homocysteine levels in placenta in pregnant women with pre-eclampsia. J Obstet Gynaecol Res 2011;37:45-50.
30. Peña-Reyes CA, Sipper M. Evolutionary computation in medicine: an overview. Artif Intell Med 2000;19:1-23. (Pubitemid 30184862)
31. Whitley D. An overview of evolutionary algorithms: practical issues and common pitfalls. Info Software Tech 2001;43:87-31.
32. Goodcare R. Making sense of the metabolome using evolutionary computing: seeing the wood with the trees. J Exp Bot 2005;56:245-254.
33. Miranda V, Srinivasan D, Proenca LM. Evolutionary computation in power systems. Elec Power Energ Sys 1998;20:89-98. (Pubitemid 127432176)
34. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 2011;31:66-74.
35. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53:812-818.
36. Bahado-Singh RO, Jodicke C. Uterine artery Doppler in first-trimester pregnancy screening. Clin Obstet Gynecol 2010;53:879-887.
37. Kenny LC, Broadhurst DI, Dunn W, Brown M, North RA, McCowan L, Roberts C, et al.; Screening for Pregnancy Endpoints Consortium. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension 2010;56:741-749.
38. Odibo AO, Goetzinger KR, Odibo L, Cahill AG, Macones GA, Nelson DM, Dietzen DJ. First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study. Prenat Diagn 2011; 31:990-994.